MoneyWorks4Me

Colinz Laboratories - Quaterly Results

31 Oct 2022 Evaluate
The revenue slipped marginally during the September 2022 quarter. A decline of about Rs. 19.17 millions was observed as compared to Rs. 19.51 millions during the corresponding quarter last year.A slim rise of 17.00% was recorded in the Net profit for the quarter ended September 2022 to Rs. 1.17  millions  From Rs. 1.00 millions.Operating profit for the quarter ended September 2022 rose to 2.12 millions as compared to 2.06 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 19.17 19.51 -1.74 37.55 38.01 -1.21 69.74 61.59 13.23
Other Income 0.45 0.29 55.17 0.86 0.70 22.86 1.71 1.91 -10.47
PBIDT 2.12 2.06 2.91 3.99 3.87 3.10 7.57 5.22 45.02
Interest 0.13 0.19 -31.58 0.25 0.39 -35.90 0.76 0.87 -12.64
PBDT 1.99 1.87 6.42 3.74 3.48 7.47 6.81 4.35 56.55
Depreciation 0.32 0.50 -36.00 0.64 1.00 -36.00 2.01 1.91 5.24
PBT 1.67 1.37 21.90 3.10 2.48 25.00 4.80 2.44 96.72
TAX 0.50 0.37 35.14 0.83 0.65 27.69 1.41 0.38 271.05
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.09 -0.40 -77.50
PAT 1.17 1.00 17.00 2.27 1.83 24.04 3.39 2.06 64.56
Equity 25.19 35.45 -28.94 25.19 45.71 -44.89 35.45 35.45 0.00
PBIDTM(%) 11.06 10.56 4.74 10.63 10.18 4.36 10.85 8.48 28.07
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..